Adaptimmune Therapeutics PLC financial data

Symbol
ADAP, ADAPY on OTC
Location
Abingdon, Oxfordshire
Fiscal year end
31 December
Latest financial report
10-Q - Q2 2025 - 13 Aug 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 266% % -9.1%
Quick Ratio 14% %
Debt-to-equity -5249% % -1531%
Return On Assets -80% % -218%
Operating Margin -252% % -363%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1,590,309,546 shares 3.6%
Common Stock, Shares, Outstanding 1,590,309,546 shares 3.7%
Entity Public Float $230,884,394 USD 21%
Common Stock, Value, Issued $2,156,000 USD 3.5%
Weighted Average Number of Shares Outstanding, Basic 1,584,522,868 shares 3.3%
Weighted Average Number of Shares Outstanding, Diluted 1,584,522,868 shares 1.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $13,677,000 USD -89%
Revenue from Contract with Customer, Excluding Assessed Tax $65,085,000 USD -54%
Research and Development Expense $125,241,000 USD -15%
General and Administrative Expense $71,858,000 USD -0.89%
Costs and Expenses $229,305,000 USD 4.9%
Operating Income (Loss) $164,220,000 USD -113%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $166,045,000 USD -133%
Income Tax Expense (Benefit) $3,711,000 USD 243%
Net Income (Loss) Attributable to Parent $169,756,000 USD -134%
Earnings Per Share, Basic 0 USD/shares -140%
Earnings Per Share, Diluted 0 USD/shares -83%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $26,061,000 USD -88%
Accounts Receivable, after Allowance for Credit Loss, Current $9,313,000 USD 299%
Inventory, Net $11,411,000 USD
Other Assets, Current $3,516,000 USD 7%
Assets, Current $78,115,000 USD -69%
Property, Plant and Equipment, Net $28,152,000 USD -39%
Operating Lease, Right-of-Use Asset $18,748,000 USD 3%
Intangible Assets, Net (Excluding Goodwill) $3,807,000 USD 282%
Other Assets, Noncurrent $94,000 USD
Assets $130,633,000 USD -59%
Accounts Payable, Current $9,418,000 USD 25%
Employee-related Liabilities, Current $7,594,000 USD -21%
Accrued Liabilities, Current $24,526,000 USD -20%
Contract with Customer, Liability, Current $10,700,000 USD -72%
Liabilities, Current $51,513,000 USD -37%
Contract with Customer, Liability, Noncurrent $101,419,000 USD
Operating Lease, Liability, Noncurrent $18,491,000 USD 8.1%
Other Liabilities, Noncurrent $4,493,000 USD 212%
Liabilities $201,591,000 USD -11%
Accumulated Other Comprehensive Income (Loss), Net of Tax $10,612,000 USD -211%
Retained Earnings (Accumulated Deficit) $1,171,911,000 USD -17%
Stockholders' Equity Attributable to Parent $70,958,000 USD -174%
Liabilities and Equity $130,633,000 USD -59%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $66,592,000 USD -108%
Net Cash Provided by (Used in) Financing Activities $25,320,000 USD -187%
Net Cash Provided by (Used in) Investing Activities $41,154,000 USD
Common Stock, Shares Authorized 2,108,130,546 shares 3.4%
Common Stock, Shares, Issued 1,590,309,546 shares 3.7%
Common Stock, Par or Stated Value Per Share 0 GBP/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $50,202,000 USD -1339%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $27,778,000 USD -87%
Deferred Tax Assets, Valuation Allowance $309,488,000 USD 4.9%
Deferred Tax Assets, Gross $313,099,000 USD 3.7%
Operating Lease, Liability $23,005,000 USD 2.7%
Depreciation $2,291,000 USD -17%
Payments to Acquire Property, Plant, and Equipment $1,203,000 USD 1079%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $176,956,000 USD -143%
Lessee, Operating Lease, Liability, to be Paid $29,845,000 USD 12%
Property, Plant and Equipment, Gross $83,202,000 USD -14%
Operating Lease, Liability, Current $4,514,000 USD -15%
Lessee, Operating Lease, Liability, to be Paid, Year Two $4,391,000 USD -21%
Lessee, Operating Lease, Liability, to be Paid, Year One $4,774,000 USD 40%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 26%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $6,840,000 USD 64%
Lessee, Operating Lease, Liability, to be Paid, Year Three $4,443,000 USD 1.8%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $4,496,000 USD -19%
Additional Paid in Capital $1,109,409,000 USD 0.88%
Deferred Tax Assets, Net of Valuation Allowance $3,611,000 USD -49%
Share-based Payment Arrangement, Expense $1,067,000 USD -109%